agent.disease-and-advisory

摘要

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.

詳細內容

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.

關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---

萃取時間: 2026-02-05T15:10:06Z 資料來源: CDC MMWR